Your browser doesn't support javascript.
Prolonged incubation of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in a patient on rituximab therapy.
Koff, Alan G; Laurent-Rolle, Maudry; Hsu, Jack Chun-Chieh; Malinis, Maricar.
  • Koff AG; Section of Infectious Diseases, Department of Internal Medicine, University of California Davis, Davis, California.
  • Laurent-Rolle M; Section of Infectious Diseases, Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut.
  • Hsu JC; Departments of Immunobiology and Cell Biology, Yale University School of Medicine, New Haven, Connecticut.
  • Malinis M; Section of Infectious Diseases, Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut.
Infect Control Hosp Epidemiol ; 42(10): 1286-1288, 2021 10.
Article in English | MEDLINE | ID: covidwho-1428654
ABSTRACT
The incubation period of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is rarely >14 days. We report a patient with hypogammaglobulinemia who developed coronavirus disease 2019 (COVID-19) with a confirmed incubation period of at least 21 days. These findings raise concern for a prolonged presymptomatic transmission phase, necessitating a longer quarantine duration in this patient population.
Subject(s)

Full text: Available Collection: International databases Database: MEDLINE Main subject: SARS-CoV-2 / COVID-19 Type of study: Case report Limits: Humans Language: English Journal: Infect Control Hosp Epidemiol Journal subject: Communicable Diseases / Nursing / Epidemiology / Hospitals Year: 2021 Document Type: Article

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: SARS-CoV-2 / COVID-19 Type of study: Case report Limits: Humans Language: English Journal: Infect Control Hosp Epidemiol Journal subject: Communicable Diseases / Nursing / Epidemiology / Hospitals Year: 2021 Document Type: Article